XML 60 R43.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue Recognition Disaggregation of Revenue by type of activity and reporting segment (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Disaggregation of Revenue [Line Items]        
Inter-segment revenue elimination $ (5.0) $ (3.0) $ (11.0) $ (6.0)
Net revenue 1,217.0 911.0 2,242.0 1,757.0
Biologics        
Disaggregation of Revenue [Line Items]        
Net revenue 638.0 404.0 1,184.0 781.0
Biologics | Manufacturing & Commercial Product Supply        
Disaggregation of Revenue [Line Items]        
Net revenue 169.0 124.0 303.0 214.0
Biologics | Development Services        
Disaggregation of Revenue [Line Items]        
Net revenue 469.0 280.0 881.0 567.0
Biologics | Clinical Supply Services        
Disaggregation of Revenue [Line Items]        
Net revenue 0.0 0.0 0.0 0.0
Softgel and Oral Technologies        
Disaggregation of Revenue [Line Items]        
Net revenue 329.0 247.0 572.0 468.0
Softgel and Oral Technologies | Manufacturing & Commercial Product Supply        
Disaggregation of Revenue [Line Items]        
Net revenue 289.0 214.0 496.0 405.0
Softgel and Oral Technologies | Development Services        
Disaggregation of Revenue [Line Items]        
Net revenue 40.0 33.0 76.0 63.0
Softgel and Oral Technologies | Clinical Supply Services        
Disaggregation of Revenue [Line Items]        
Net revenue 0.0 0.0 0.0 0.0
Oral and Specialty Drug Delivery        
Disaggregation of Revenue [Line Items]        
Net revenue 156.0 170.0 302.0 328.0
Oral and Specialty Drug Delivery | Manufacturing & Commercial Product Supply        
Disaggregation of Revenue [Line Items]        
Net revenue 96.0 114.0 184.0 217.0
Oral and Specialty Drug Delivery | Development Services        
Disaggregation of Revenue [Line Items]        
Net revenue 60.0 56.0 118.0 111.0
Oral and Specialty Drug Delivery | Clinical Supply Services        
Disaggregation of Revenue [Line Items]        
Net revenue 0.0 0.0 0.0 0.0
Clinical Supply Services        
Disaggregation of Revenue [Line Items]        
Net revenue 99.0 93.0 195.0 186.0
Clinical Supply Services | Manufacturing & Commercial Product Supply        
Disaggregation of Revenue [Line Items]        
Net revenue 0.0 0.0 0.0 0.0
Clinical Supply Services | Development Services        
Disaggregation of Revenue [Line Items]        
Net revenue 0.0 0.0 0.0 0.0
Clinical Supply Services | Clinical Supply Services        
Disaggregation of Revenue [Line Items]        
Net revenue 99.0 93.0 195.0 186.0
Total Catalent before inter-segment revenue elimination        
Disaggregation of Revenue [Line Items]        
Net revenue 1,222.0 914.0 2,253.0 1,763.0
Total Catalent before inter-segment revenue elimination | Manufacturing & Commercial Product Supply        
Disaggregation of Revenue [Line Items]        
Net revenue 554.0 452.0 983.0 836.0
Total Catalent before inter-segment revenue elimination | Development Services        
Disaggregation of Revenue [Line Items]        
Net revenue 569.0 369.0 1,075.0 741.0
Total Catalent before inter-segment revenue elimination | Clinical Supply Services        
Disaggregation of Revenue [Line Items]        
Net revenue $ 99.0 $ 93.0 $ 195.0 $ 186.0